Literature DB >> 8250258

A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene.

T Yagi1, S Nada, N Watanabe, H Tamemoto, N Kohmura, Y Ikawa, S Aizawa.   

Abstract

In producing mutant mice by gene targeting in embryonic stem (ES) cells, the efficient isolation of the homologous recombinants is still a critical step. We previously reported on a negative selection using the diphtheria toxin A (DT-A) fragment gene for homologous recombinants (1). It was efficient but limited to gene loci expressed in ES cells. For wider applicability of this negative selection to many gene loci not expressed or expressed at low levels in ES cells, we exploited a novel targeting vector composed of a polyA-less neo gene, a mRNA destabilizing signal, a pausing signal for RNA polymerase II from the minute virus of mice, and the DT-A gene. There was about a 30-fold decrease in frequency of G418-resistant colonies with this strategy against that using only the neo gene in the vector, and homologous recombinants were obtained at frequencies of more than 1/50 among G418 resistant cells at fyn, csk, c-mos, and insulin receptor substrate-1 gene loci.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250258     DOI: 10.1006/abio.1993.1459

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  75 in total

1.  Cerebellar granule cell-specific and inducible expression of Cre recombinase in the mouse.

Authors:  M Tsujita; H Mori; M Watanabe; M Suzuki; J Miyazaki; M Mishina
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Enrichment and efficient screening of ES cells containing a targeted mutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker.

Authors:  Y Yanagawa; T Kobayashi; M Ohnishi; T Kobayashi; S Tamura; T Tsuzuki; M Sanbo; T Yagi; F Tashiro; J Miyazaki
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

3.  Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice.

Authors:  N Uetani; K Kato; H Ogura; K Mizuno; K Kawano; K Mikoshiba; H Yakura; M Asano; Y Iwakura
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Immunocytochemical analyses and targeted gene disruption of GTPBP1.

Authors:  S Senju; K Iyama; H Kudo; S Aizawa; Y Nishimura
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia.

Authors:  Hitomi Yamamoto; Koichi Kokame; Tomohiko Okuda; Yukako Nakajo; Hiroji Yanamoto; Toshiyuki Miyata
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

7.  Nav2/NaG channel is involved in control of salt-intake behavior in the CNS.

Authors:  E Watanabe; A Fujikawa; H Matsunaga; Y Yasoshima; N Sako; T Yamamoto; C Saegusa; M Noda
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

8.  A type I DnaJ homolog, DjA1, regulates androgen receptor signaling and spermatogenesis.

Authors:  Kazutoyo Terada; Kentaro Yomogida; Tomoaki Imai; Hiroshi Kiyonari; Naoki Takeda; Tsuyoshi Kadomatsu; Masato Yano; Shinichi Aizawa; Masataka Mori
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

9.  Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves.

Authors:  Tomohiko Okuda; Yujiro Higashi; Koichi Kokame; Chihiro Tanaka; Hisato Kondoh; Toshiyuki Miyata
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Studies on homologous recombination in the green alga Chlamydomonas reinhardtii.

Authors:  N J Gumpel; J D Rochaix; S Purton
Journal:  Curr Genet       Date:  1994 Nov-Dec       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.